SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    An Tang, Ajinkya Desai, Gavin Hamilton, Tanya Wolfson, Anthony Gamst, Jessica Lam, Lisa Clark, Jonathan Hooker, Tanya Chavez, Brandon D. Ang, Michael S. Middleton, Michael Peterson, Rohit Loomba, Claude B. Sirlin, Accuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease, Radiology, 2015, 274, 2, 416

    CrossRef

  2. 2
    Ahilan Arulanandan, Brandon Ang, Ricki Bettencourt, Jonathan Hooker, Cynthia Behling, Grace Y. Lin, Mark A. Valasek, Joachim H. Ix, Bernd Schnabl, Claude B. Sirlin, Rohit Loomba, Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis, Clinical Gastroenterology and Hepatology, 2015, 13, 8, 1513

    CrossRef

  3. 3
    Paul Murphy, Jonathan Hooker, Brandon Ang, Tanya Wolfson, Anthony Gamst, Mark Bydder, Michael Middleton, Michael Peterson, Cynthia Behling, Rohit Loomba, Claude Sirlin, Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults, Journal of Magnetic Resonance Imaging, 2015, 41, 6
  4. 4
    Fernando Bril, Carolina Ortiz-Lopez, Romina Lomonaco, Beverly Orsak, Michael Freckleton, Kedar Chintapalli, Jean Hardies, Song Lai, Felipe Solano, Fermin Tio, Kenneth Cusi, Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients, Liver International, 2015, 35, 8
  5. You have free access to this content5
    J. Cui, B. Ang, W. Haufe, C. Hernandez, E. C. Verna, C. B. Sirlin, R. Loomba, Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study, Alimentary Pharmacology & Therapeutics, 2015, 41, 12
  6. 6
    Guido M. Kukuk, Kanishka Hittatiya, Alois M. Sprinkart, Holger Eggers, Jürgen Gieseke, Wolfgang Block, Philipp Moeller, Winfried A. Willinek, Ulrich Spengler, Jonel Trebicka, Hans-Peter Fischer, Hans H. Schild, Frank Träber, Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis, European Radiology, 2015,

    CrossRef

  7. 7
    Niraj S. Patel, Iliana Doycheva, Michael R. Peterson, Jonathan Hooker, Tatiana Kisselva, Bernd Schnabl, Ekihiro Seki, Claude B. Sirlin, Rohit Loomba, Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis, Clinical Gastroenterology and Hepatology, 2015, 13, 3, 561

    CrossRef

  8. 8
    Rohit Loomba, Helena Cortez-Pinto, Exercise and improvement of NAFLD: Practical recommendations, Journal of Hepatology, 2015, 63, 1, 10

    CrossRef

  9. 9
    Rohit Loomba, Claude B. Sirlin, Brandon Ang, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Linda Soaft, Jonathan Hooker, Yuko Kono, Archana Bhatt, Laura Hernandez, Phirum Nguyen, Mazen Noureddin, William Haufe, Catherine Hooker, Meng Yin, Richard Ehman, Grace Y. Lin, Mark A. Valasek, David A. Brenner, Lisa Richards, Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial), Hepatology, 2015, 61, 4
  10. You have free access to this content10
    C. E. Ruhl, J. E. Everhart, Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey, Alimentary Pharmacology & Therapeutics, 2015, 41, 1
  11. 11
    Kun Young Kim, Ji Soo Song, Stephan Kannengiesser, Young Min Han, Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area, La radiologia medica, 2015,

    CrossRef

  12. 12
    Ji Cheol Bae, Won Young Lee, Kun Ho Yoon, Joong Yeol Park, Hyun Sik Son, Kyung Ah Han, Kwan Woo Lee, Jeong Taek Woo, Young Cheol Ju, Won Jae Lee, Yoon Young Cho, Moon-Kyu Lee, Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial, Diabetes Care, 2015, 38, 7, 1245

    CrossRef

  13. 13
    Gavin Hamilton, Michael S. Middleton, Jonathan C. Hooker, William M. Haufe, Nketi I. Forbang, Matthew A. Allison, Rohit Loomba, Claude B. Sirlin, In vivo breath-hold 1H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence, Journal of Magnetic Resonance Imaging, 2015, 42, 2
  14. 14
    Vincent Wai-Sun Wong, Grace Lai-Hung Wong, David Ka-Wai Yeung, Tina Kit-Ting Lau, Carmen Ka-Man Chan, Angel Mei-Ling Chim, Jill M. Abrigo, Ruth Suk-Mei Chan, Jean Woo, Yee-Kit Tse, Winnie Chiu-Wing Chu, Henry Lik-Yuen Chan, Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy, Journal of Hepatology, 2015, 62, 1, 182

    CrossRef

  15. 15
    Christophe Cassinotto, Matthieu Feldis, Julien Vergniol, Amaury Mouries, Hubert Cochet, Bruno Lapuyade, Arnaud Hocquelet, Etienne Juanola, Juliette Foucher, François Laurent, Victor De Ledinghen, MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity, European Journal of Radiology, 2015, 84, 8, 1459

    CrossRef

  16. 16
    Mazen Noureddin, Cyrus Khoyilar, Suzanne L. Palmer, MRI, CT Scan, and Ultrasound in the Diagnosis of Nonalcoholic Fatty Liver Disease, Journal of Clinical Gastroenterology, 2015, 49, 4, 351

    CrossRef

  17. 17
    Leon A. Adams, NAFLD: Accurate quantification of hepatic fat—is it important?, Nature Reviews Gastroenterology & Hepatology, 2015, 12, 3, 126

    CrossRef

  18. 18
    Claudia Filozof, Barry J. Goldstein, Richard N. Williams, Arun Sanyal, Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway, Drugs, 2015,

    CrossRef

  19. 19
    Steven C. Lin, Elhamy Heba, Tanya Wolfson, Brandon Ang, Anthony Gamst, Aiguo Han, John W. Erdman, William D. O’Brien, Michael P. Andre, Claude B. Sirlin, Rohit Loomba, Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique, Clinical Gastroenterology and Hepatology, 2015, 13, 7, 1337

    CrossRef

  20. 20
    E. C. Verna, J. Patel, R. Bettencourt, P. Nguyen, C. Hernandez, M. A. Valasek, T. Kisselva, D. A. Brenner, R. Loomba, Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2015, 42, 4
  21. 21
    Stefania Mariani, Daniela Fiore, Sabrina Basciani, Agnese Persichetti, Savina Contini, Carla Lubrano, Luisa Salvatori, Andrea Lenzi, Lucio Gnessi, Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients, Endocrine, 2015, 49, 3, 711

    CrossRef

  22. 22
    Mustafa R. Bashir, Xiaodong Zhong, Marcel D. Nickel, Ghaneh Fananapazir, Stephan A. R. Kannengiesser, Berthold Kiefer, Brian M. Dale, Quantification of Hepatic Steatosis With a Multistep Adaptive Fitting MRI Approach: Prospective Validation Against MR Spectroscopy, American Journal of Roentgenology, 2015, 204, 2, 297

    CrossRef

  23. 23
    Stefania Galimberti, Paola Trombini, Davide Paolo Bernasconi, Irene Redaelli, Sara Pelucchi, Giorgio Bovo, Filiberto Di Gennaro, Nicola Zucchini, Nicoletta Paruccini, Alberto Piperno, Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia, Scandinavian Journal of Gastroenterology, 2015, 50, 4, 429

    CrossRef

  24. 24
    HeiShun Yu, Karen Buch, Baojun Li, Michael O'Brien, Jorge Soto, Hernan Jara, Stephan W. Anderson, Utility of texture analysis for quantifying hepatic fibrosis on proton density MRI, Journal of Magnetic Resonance Imaging, 2015, 42, 2
  25. 25
    Mi-Jung Jun, Ju Hyun Shim, So Yeon Kim, Nieun Seo, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Eunsil Yu, Sung-Gyu Lee, Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation, Liver Transplantation, 2014, 20, 4
  26. 26
    L. Stinton, R. Loomba, Commentary: dissecting the PNPLA3 association with liver fat and stiffness, and interaction with diet, Alimentary Pharmacology & Therapeutics, 2014, 39, 8
  27. 27
    Keyur Patel, Nicholas A. Shackel, Current status of fibrosis markers, Current Opinion in Gastroenterology, 2014, 30, 3, 253

    CrossRef

  28. You have free access to this content28
    Peter Bannas, Diego Hernando, Utaroh Motosugi, Alejandro Roldan, Scott Brian Reeder, Emerging quantitative MRI biomarkers of diffuse liver disease, Clinical Liver Disease, 2014, 4, 6
  29. 29
    Ilkay S. Idilman, Onur Keskin, Atilla Halil Elhan, Ramazan Idilman, Musturay Karcaaltincaba, Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease, Scandinavian Journal of Gastroenterology, 2014, 49, 5, 617

    CrossRef

  30. 30
    Rohit Loomba, Tanya Wolfson, Brandon Ang, Jonathan Hooker, Cynthia Behling, Michael Peterson, Mark Valasek, Grace Lin, David Brenner, Anthony Gamst, Richard Ehman, Claude Sirlin, Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study, Hepatology, 2014, 60, 6
  31. 31
    Kotacherry T. Shenoy, Leena K. Balakumaran, Philip Mathew, Mohan Prasad, Boddu Prabhakar, Ajit Sood, Shivaram P. Singh, Nagaraj P. Rao, Shoukat A. Zargar, Angelo A. Bignamini, Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial, Journal of Clinical and Experimental Hepatology, 2014, 4, 2, 94

    CrossRef

  32. 32
    Rohit Loomba, Serum Alanine Aminotransferase as a Biomarker of Treatment Response in Nonalcoholic Steatohepatitis, Clinical Gastroenterology and Hepatology, 2014, 12, 10, 1731

    CrossRef

  33. 33
    Michelle Pearlman, Rohit Loomba, State of the art, Current Opinion in Gastroenterology, 2014, 30, 3, 223

    CrossRef

  34. 34
    Scott B. Reeder, Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis, Hepatology, 2013, 58, 6
  35. 35
    Niraj S. Patel, Michael R. Peterson, Grace Y. Lin, Ariel Feldstein, Bernd Schnabl, Ricki Bettencourt, Ekihiro Seki, Claude B. Sirlin, Rohit Loomba, Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls, Gastroenterology Research and Practice, 2013, 2013, 1

    CrossRef